AMS INSIGHT 1 Study - Bioabsorbable Metal Stent Investigation in Chronic Limb Ischemia Treatment (AMS-INSIGHT1)
Bioabsorbable Metal Stent Investigation in Chronic Limb Ischemia Treatment
Sponsor: Biotronik SE & Co. KG
A PHASE2 clinical study on Peripheral Artery Disease, this trial is completed. The trial is conducted by Biotronik SE & Co. KG and has accumulated 6 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Jul 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biotronik SE & Co. KG
- Flanders Medical Research Program
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Antwerp, Belgium , Bad Krozingen, Germany , Bad Saarow, Germany , Berlin, Germany , Bonheiden, Belgium , Dendermonde, Belgium , Graz, Austria , Klagenfurt, Austria , Leipzig, Germany , Mainz, Germany and 2 more locations